Biosensor Partnerships General Graphene has a proven track record with biosensor manufacturers and mass production partners, having collaborated with Hememics, GrapheneDx, and Sapphiros to scale graphene biosensors for point-of-care diagnostics. This indicates a strong fit as a supplier for device makers seeking scalable graphene materials and roll-to-roll processing, with opportunities to engage additional biosensor startups, contract manufacturers, and OEMs developing rapid tests and wearable sensors.

Scale Advantage The company operates industrial scale CVD roll-to-roll graphene and carbon materials with proprietary manufacturing technology, enabling high-volume supply of graphene films and 3D foams. This capability aligns with customers pursuing commercialization and volume production, with an opportunity to target large volume manufacturers in batteries, sensors, and membranes that need reliable graphene material streams.

Multi Industry Outreach A diverse collaboration portfolio spanning sensors, flexible electronics, healthcare, battery research, and membranes demonstrates broad applicability and cross selling potential. Sales teams can tailor offerings per segment, from flexible electronics substrates to energy storage materials, filtration membranes, and biosensor components.

Funding Readiness With funding in place and a trajectory toward commercialization, General Graphene is positioned to pursue strategic partnerships, grants, or joint development agreements to accelerate productization of graphene materials, enabling customers to de-risk scale up and reduce time to market.

Material Portfolio The portfolio includes CVD Graphene Films, 3D Graphene Foams, and Pyrolytic Carbon Films, enabling tailoring of material selections to customer needs across sensors, energy storage, filtration, and membranes.